We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Biotest AG (PK) | USOTC:BTTAY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 24.27 | 16.93 | 54.95 | 0.00 | 21:07:41 |
From Jun 2019 to Jun 2024
Germany's Merck KGaA (MRK.XE) said Tuesday it has entered into a definitive agreement to acquire the microbiology business of Biotest AG (BIO.XE), Germany.
MAIN FACTS:
-A Merck spokesman Tuesday said the purchase price was up to EUR101 million before tax.
-The business has approximately 290 employees and generated sales of approximately EUR50 million in 2010.
-This business comprises heipha Dr. Muller GmbH, located in Eppelheim, Germany, as well as the Hycon business located in Dreieich, the subsidiaries in France, Japan and in the USA as well as further activities and employees in several European countries.
-The agreement is subject to antitrust approvals in Germany and Austria.
-Closing of the transaction is expected in the second half of 2011.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
1 Year Biotest (PK) Chart |
1 Month Biotest (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
